Trinity Biotech | TRIB - Ebitda





Ebitda Veränderung Datum
Abbott USD 2.43B 844M 2026-03
Bayer EUR 1.62B 529M 2026-09
Bio-Rad Laboratories USD 119.9M 475.4M 2026-09
EDAP TMS EUR -6.47M 1.54M 2026-03
J&J USD 8.99B 721M 2026-06
Mesa Laboratories USD 9.58M 1.47M 2024-09
OraSure Technologies USD -17.7M 4.06M 2025-12
Plus Therapeutics USD -4.4M 2.94M 2025-09
Roche Holding CHF 13.43B 744M 2026-06
Siemens EUR 4.2B 644M 2026-06
Thermo Fisher Scientific USD 3.79B 244M 2026-09
Tosoh JPY 39.13B 286M 2024-12
Trinity Biotech USD -9.6M 7.64M 2024-12
Veracyte USD 41.24M 2.72M 2026-09